# Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial

> **NCT05782777** · NA · RECRUITING · sponsor: **Yonsei University** · enrollment: 4310 (estimated)

## Conditions studied

- Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation

## Interventions

- **DRUG:** ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
- **DRUG:** high-intensity statin monotherapy (atoravastatin 40mg)

## Key facts

- **NCT ID:** NCT05782777
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-07
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 4310 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05782777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05782777, "Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05782777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*